Why I Just Bought Canopy Growth (TSX:WEED)

By now, you’re probably well aware that Canopy Growth’s (TSX:WEED)(NYSE:CGC) last quarter was a major disappointment. Recreational cannabis sales came in well below estimates and signaled Canopy was losing market share in the face of rising competition. Furthermore, margins completely eroded due to underutilization of production equipment combined with a revenue mix that weighed more towards lower-margin dried cannabis instead…

Read More

Should You Buy Canopy Growth (TSX:WEED)?

In case you haven’t noticed, Canada’s enviable cannabis sector has been busting more than booming lately. In the months and weeks counting down to legalization, cannabis stocks such as Canopy Growth (TSX:WEED)(NYSE:CGC) shot well into the stratosphere. Unfortunately, after a rally in the early part of the year, pot stocks have taken a turn and dropped sharply. In the case…

Read More

Cannabis Investor Alert: Aphria (TSX:APHA) Is Correcting an Earlier Certification Mistake

Management’s strategic choices at the outset of a new business venture can significantly influence future financial successes or failures, and it’s encouraging to see executives at a cannabis growth stock like Aphria (TSX:APHA)(NYSE:APHA) quickly learning from and correcting a seemingly early mistake made in 2018 to give the company a new market access. I questioned the company’s choice of a…

Read More

The Big Problem With Investing in Aurora Cannabis (TSX:ACB) Today

Aurora Cannabis (TSX:ACB)(NYSE:ACB) is expected to release its quarterly results next month. And with strong revenue numbers per the company’s most recent update, it might be on its way to becoming the top cannabis company in Canada. As good as the company’s prospects may look, especially with edibles soon to be legalized, the stock may still not be a good investment…

Read More

Investors: Hers’s Why Aphria (TSX:APHA) Is a Solid Long-Term Pick

Shares of Aphria (TSX:APHA)(NYSE:APHA) have made a strong comeback recently. The stock has gained 25% since the start of August 2019. While Aphria shares have fallen 60% since September last year, they are up by an impressive 1,050% since its IPO in December 2014. Most cannabis stocks have generated significant returns in the last five years, despite a steep pullback…

Read More

KALY – Kali Extracts Confirms Analyst Report On Cannabis Extract Biopharmaceutical Strategy Scheduled For Publication Next Week

Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today confirmed the publication of an analyst report covering the company’s overall cannabis extract biopharmaceutical strategy is scheduled for next week on Wednesday, August 28, 2019. After making a strategic acquisition in Q4 2018 of a business with a U.S. Patented Cannabis Extraction Process, KALY has just posted its 2019 YTD financials…

Read More